These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19429530)

  • 1. A European biotechnology transfer platform?
    Suojanen C
    N Biotechnol; 2009 Apr; 25(4):167-8. PubMed ID: 19429530
    [No Abstract]   [Full Text] [Related]  

  • 2. The Netherlands innovation utilising.
    Med Device Technol; 2008 Sep; 19(5):58-9. PubMed ID: 18947153
    [No Abstract]   [Full Text] [Related]  

  • 3. European research infrastructures for the development of nanobiotechnologies.
    Péro H; Faure JE
    Trends Biotechnol; 2007 May; 25(5):191-4. PubMed ID: 17368840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaysia tiptoes on the heels of Asian neighbors.
    Fuyuno I
    Nat Biotechnol; 2005 Aug; 23(8):908-9. PubMed ID: 16082349
    [No Abstract]   [Full Text] [Related]  

  • 5. Chinese biotech: the need for innovation and higher standards.
    Wong GH
    Nat Biotechnol; 2006 Feb; 24(2):221-2. PubMed ID: 16465169
    [No Abstract]   [Full Text] [Related]  

  • 6. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First U.S.-Russian business venture in closed nuclear city.
    Lopatto J; Wilkes B
    Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
    [No Abstract]   [Full Text] [Related]  

  • 9. Transferring EU-funded biotechnology research to European bioindustry.
    Lawler C; van der Meer R; Viseur J
    Nat Biotechnol; 1998 Jun; 16(6):494. PubMed ID: 9624665
    [No Abstract]   [Full Text] [Related]  

  • 10. Pan-EU Biobanks.
    Nasto B
    Nat Biotechnol; 2008 Jul; 26(7):725. PubMed ID: 18612283
    [No Abstract]   [Full Text] [Related]  

  • 11. India's strategy to bridge the public-private divide.
    Jayaraman KS
    Nat Biotechnol; 2005 May; 23(5):523. PubMed ID: 15942982
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology transfer across industries.
    Woodley D
    Med Device Technol; 2004 Dec; 15(10):18-21. PubMed ID: 16225279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indian biotechs partner with government.
    Jayaraman KS
    Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352355
    [No Abstract]   [Full Text] [Related]  

  • 14. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 15. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea.
    Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY
    Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865
    [No Abstract]   [Full Text] [Related]  

  • 16. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 17. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 18. Ireland: delivering today and tomorrow.
    Med Device Technol; 2007 Oct; 18(6):43. PubMed ID: 18078182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the university-industrial complex out of control?
    Nature; 2001 Jan; 409(6817):119. PubMed ID: 11196604
    [No Abstract]   [Full Text] [Related]  

  • 20. Singapore R&D and globetrotting.
    Lear MJ; Salmons B; Gunzburg WH; Dangerfield JA
    Biotechnol J; 2009 Feb; 4(2):179-85. PubMed ID: 19156748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.